IFNα4 is involved in lymphocyte activation as well as anti-tumor immunity, whereas IFNβ balances expression of pro- and anti-inflammatory agents in addition to inhibiting T cell activation and proliferation (Boukhaled et al., 2021). This evidence concerns the gene IFNA4 and neoplasm.